This case of an unusual but important cause of dystonia brings forth some key insights about the use of neuromodulation therapy for this still-uncommon indication.
Findings of this milestone investigation suggest that analgesia may not be the appropriate therapy goal in central pain syndromes and that neuromodulation should focus on pain-related suffering and disability.
Through a nuanced podcast and a short video, neurosurgeon Andre Machado, MD, PhD, is spreading the word about why he hopes deep brain stimulation can improve motor recovery for stroke survivors.
A study of patients’ symptom and behavioral goals prior to deep brain stimulation for Parkinson’s suggests treatment success involves far more than standard clinical metrics.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
A scientist involved in Cleveland Clinic’s newly launched study of neuromodulation for post-stroke recovery speaks to the science behind the trial and the NIH BRAIN grant supporting this work.
For the first time, deep brain stimulation electrodes have been implanted in a stroke survivor to restore lost motor function. The aim is to boost rehabilitation beyond what physical therapy can do alone.
Deep brain stimulation has never before been used to help recover lost motor function. Cleveland Clinic researchers are now enrolling disabled stroke survivors in a trial to see if it can.
The first-in-human trial of neuromodulation for rehabilitative therapy in stroke survivors has been given a boost with a $5 million grant. The lead investigator explains the study’s goals and rationale.
This new deep brain stimulation paradigm uses lower individual pulse amplitudes to reduce the risk of side effects. It shows promise in preclinical parkinsonian models while shedding light on DBS’ therapeutic mechanisms.
Cleveland Clinic announces it’s ready to start enrollment in a pioneering trial of deep brain stimulation following official clearance from the FDA.